Pulmonary complications of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with hematological malignancies

V.O. Sarzhevskiy, V.Ya. Melnichenko, V.P. Tyurin,

DOI:

https://doi.org/10.21320/2500-2139-2014-7-1-76-85

This review presents the recent data on the pulmonary complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with hematological malignancies. The detailed information on the diagnostic approaches, pathogenetic and clinical features, prevention and treatment of the early and late pulmonary toxicity is provided.

  • V.O. Sarzhevskiy N.I. Pirogov National Medico-surgical Center, RF MH, Moscow, Russian Federation ; ФГБУ «Национальный медико-хирургический центр им. Н.И. Пирогова» МЗ РФ, Москва, Российская Федерация
  • V.Ya. Melnichenko N.I. Pirogov National Medico-surgical Center, RF MH, Moscow, Russian Federation ; ФГБУ «Национальный медико-хирургический центр им. Н.И. Пирогова» МЗ РФ, Москва, Российская Федерация
  • V.P. Tyurin N.I. Pirogov National Medico-surgical Center, RF MH, Moscow, Russian Federation ; ФГБУ «Национальный медико-хирургический центр им. Н.И. Пирогова» МЗ РФ, Москва, Российская Федерация
  1. Prince D.S., Wingard J.R., Saral R. et al. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 1989; 96(2): 301–6. DOI: https://doi.org/10.1378/chest.96.2.301
  2. Arvidson J., Bratteby L.E., Carlson K. et al. Pulmonary function after autologous bone marrow transplantation in children. Bone Marrow Transplant. 1994; 14(1): 117–23.
  3. Ghalie R., Szidon J.P., Thompson L. et al. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests. Bone Marrow Transplant. 1992; 10(4): 359–65.
  4. Nenadov Beck M., Meresse V., Hartmann O. et al. Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation. Bone Marrow Transplant. 1995; 16(6): 771–5.
  5. Badier M., Guillot C., Delpierre S. et al. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant. 1993; 12(5): 457–61.
  6. Ho V.T., Weller E., Lee S.J. et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 2001; 7(4): 223–9. DOI: https://doi.org/10.1053/bbmt.2001.v7.pm11349809
  7. Shannon V.R., Andersson B.S., Lei X. et al. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010; 45(4): 647–55. DOI: https://doi.org/10.1038/bmt.2009.203
  8. Hofmeister C.C., Czerlanis C., Forsythe S. et al. Retrospective utility of bronchoscopy after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006; 38(10): 693–8. DOI: https://doi.org/10.1038/sj.bmt.1705505
  9. Azoulay E., Mokart D., Rabbat A. et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit. Care Med. 2008; 36(1): 100–7. DOI: https://doi.org/10.1097/01.CCM.0000295590.33145.C4
  10. NCCN Guidelines Version 1.2012. Prevention and Treatment of CancerRelated Infection. 2012: 15.
  11. Sharma S., Nadrous H.F., Peters S.G. et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest. 2005; 128(3): 1385–92. DOI: https://doi.org/10.1378/chest.128.3.1385
  12. Roychowdhury M., Pambuccian S.E., Aslan D.L. et al. Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center. Arch. Pathol. Lab. Med. 2005; 129(3): 366–71. DOI: https://doi.org/10.5858/2005-129-366-PCABMT
  13. Munker R., Lazarus H.M., Atkinson K. The BMT Data Book, 2nd edn. Cambridge University Press, 2009: 237. DOI: https://doi.org/10.1017/CBO9780511575525
  14. Frankovich J., Donaldson S.S., Lee Y. et al. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin’s disease: atopy predicts idiopathic diffuse lung injury syndromes. Biol. Blood Marrow Transplant. 2001; 7(1): 49–57. DOI: https://doi.org/10.1053/bbmt.2001.v7.pm11215699
  15. Avivi I., Hardak E., Shaham B. et al. Low incidence of long-term respiratory impairment in Hodgkin lymphoma survivors. Ann. Hematol. 2012; 91(2): 215–21. DOI: https://doi.org/10.1007/s00277-011-1255-7
  16. Arimura K., Inoue H., Kukita T. et al. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 2005; 90(3): ECR10.
  17. Krishnan G.S., Chaudhary V., Al-Janadi A. et al. BCNU toxicity presenting with a large pericardial and pleural effusion. Ann. Transplant. 2008; 13(1): 44–7.
  18. Jones R.B., Matthes S., Shpall E.J. et al. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. J. Natl. Cancer Inst. 1993; 85(8): 640–7. DOI: https://doi.org/10.1093/jnci/85.8.640
  19. Puig N., de la Rubia J., Remigia M.J. et al. Morbidity and transplantrelated mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation. Leuk. Lymphoma 2006; 47(8): 1488–94. DOI: https://doi.org/10.1080/10428190500527769
  20. Stuart M.J., Chao N.S., Horning S.J. et al. Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin’s disease. Biol. Blood Marrow Transplant. 2001; 7(10): 552–60. DOI: https://doi.org/10.1016/S1083-8791(01)70015-8
  21. Munker R., Hilderbrandt G.C., Lazarus H.M., Atkinson K. The BMT Data Book: including cellular therapy, 3nd edn. Cambridge University Press, 2013: 282. DOI: https://doi.org/10.1017/CBO9781139519205
  22. Malik S.W., Myers J.L., DeRemee R.A. et al. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am. J. Respir. Crit. Care Med. 1996; 154(6 Pt. 1): 1851–6. DOI: https://doi.org/10.1164/ajrccm.154.6.8970380
  23. Chen C.I., Abraham R., Tsang R. et al. Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant. 2001; 27(2): 177–82. DOI: https://doi.org/10.1038/sj.bmt.1702771
  24. Afessa B., Abdulai R.M., Kremers W.K. et al. Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest 2012; 141(2): 442–50. DOI: https://doi.org/10.1378/chest.10-2889
  25. Halaburda K., Nasilowska-Adamska B., Grabarczyk P. et al. Limited predictive value of real-time quantitative PCR cytomegalovirus monitoring in the blood. Fatal CMV pneumonia in an autologous stem cell transplant recipient previously treated with alemtuzumab. Ann. Transplant. 2007; 12(2): 37–40.
  26. Mariotte E., Schnell D., Scieux C. et al. Significance of herpes-virus 6 in BAL fluid of hematology patients with acute respiratory failure. Infection 2011; 39(3): 225–30. DOI: https://doi.org/10.1007/s15010-011-0114-8
  27. Robbins R.A., Linder J., Stahl M.G. et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am. J. Med. 1989; 87(5): 511–8. DOI: https://doi.org/10.1016/S0002-9343(89)80606-0
  28. Afessa B., Tefferi A., Litzow M.R. et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am. J. Respir. Crit. Care Med. 2002; 166(5): 641–5. DOI: https://doi.org/10.1164/rccm.200112-141CC
  29. Metcalf J.P., Rennard S.I., Reed E.C. et al. Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group. Am. J. Med. 1994; 96(4): 327–34. DOI: https://doi.org/10.1016/0002-9343(94)90062-0
  30. Lee C.K., Gingrich R.D., Hohl R.J. et al. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant. 1995; 16(1): 175–82.
  31. Spitzer T.R. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001; 27(9): 893–8. DOI: https://doi.org/10.1038/sj.bmt.1703015
  32. Edenfield W.J., Moores L.K., Goodwin G. et al. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant. 2000; 25(4): 405–9. DOI: https://doi.org/10.1038/sj.bmt.1702155
  33. Nurnberger W., Willers R., Burdach S. et al. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann. Hematol. 1997; 74(5): 221–4. DOI: https://doi.org/10.1007/s002770050288
  34. Kantrow S.P., Hackman R.C., Boeckh M. et al. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63(8): 1079–86. DOI: https://doi.org/10.1097/00007890-199704270-00006
  35. Clark J.G., Hansen J.A., Hertz M.I. et al. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am. Rev. Respir. Dis. 1993; 147(6 Pt. 1): 1601–6. DOI: https://doi.org/10.1164/ajrccm/147.6_Pt_1.1601
  36. Kato H., Yamamoto K., Taji H. et al. Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-Hodgkin lymphoma. Clin. Lymph. Myel. Leuk. 2011; 11(6): 483–9. DOI: https://doi.org/10.1016/j.clml.2011.06.011
  37. Metzner B., Gruneisl R., Gebauer W. et al. Late infectious complications after high-dose therapy and autologous blood stem cell transplantation. Med. Klin. (Munich) 2002; 97(11): 650–8. DOI: https://doi.org/10.1007/s00063-002-1208-y
  38. Roy V., Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant. 1997; 19(5): 467–70. DOI: https://doi.org/10.1038/sj.bmt.1700686
  39. Akan H., Arslan O., Akan O.A. et al. Tuberculosis in stem cell transplant patients. J. Hosp. Infect. 2006; 62(4): 421–6. DOI: https://doi.org/10.1016/j.jhin.2005.09.020
  40. Marras T.K., Chan C.K. Obliterative bronchiolitis complicating bone marrow transplantation. Semin. Respir. Crit. Care Med. 2003; 24(5): 531–42. DOI: https://doi.org/10.1055/s-2004-815602
  41. Paz H.L., Crilley P., Patchefsky A., Schiffman R.L., Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992; 101(3): 775–8. DOI: https://doi.org/10.1378/chest.101.3.775
  42. Gulbahce H.E., Pambuccian S.E., Jessurun J. et al. Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosis. Am J. Clin. Pathol. 2004; 121(2): 205–10. DOI: https://doi.org/10.1309/4HYN1DEA718RDM6T
  43. Witherspoon R.P., Fisher L.D., Schoch G. et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N. Engl. J. Med. 1989; 321(12): 784–9. DOI: https://doi.org/10.1056/NEJM198909213211203
  44. Danner-Koptik K.E., Majhail N.S., Brazauskas R. et al. Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant. 2013; 48(3): 363–8. DOI: https://doi.org/10.1038/bmt.2012.166

Keywords:

high-dose chemotherapy, autologous hematopoietic stem cell transplantation, pulmonary complications

License

Copyright (c) 2014 Clinical Oncohematology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Downloads

Download data is not yet available.
2014-1

Downloads

Published

01.01.2014

Issue

Vol. 7 No. 1 (2014)
COMPLICATIONS OF CHEMOTHERAPY

How to Cite

Sarzhevskiy V.O., Melnichenko V.Y., Tyurin V.P. Pulmonary complications of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with hematological malignancies. Clinical Oncohematology. Basic Research and Clinical Practice. 2014;7(1):76–85. doi:10.21320/2500-2139-2014-7-1-76-85.

Most read articles by the same author(s)

1 2 > >>